ShockWave Medical Statistics
Total Valuation
illimity Bank has a market cap or net worth of EUR 337.53 million.
Market Cap | 337.53M |
Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | May 20, 2024 |
Share Statistics
illimity Bank has 83.01 million shares outstanding. The number of shares has decreased by -2.49% in one year.
Current Share Class | 83.01M |
Shares Outstanding | 83.01M |
Shares Change (YoY) | -2.49% |
Shares Change (QoQ) | -1.98% |
Owned by Insiders (%) | 4.06% |
Owned by Institutions (%) | 107.46% |
Float | 48.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 19.48 |
PS Ratio | -352.70 |
PB Ratio | 0.43 |
P/TBV Ratio | 0.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -24.89%.
Return on Equity (ROE) | -24.89% |
Return on Assets (ROA) | -2.72% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | -1,238 |
Profits Per Employee | -231,743 |
Employee Count | 779 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -23.36M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.44% in the last 52 weeks. The beta is 1.06, so illimity Bank's price volatility has been similar to the market average.
Beta (5Y) | 1.06 |
52-Week Price Change | -10.44% |
50-Day Moving Average | 3.87 |
200-Day Moving Average | 3.60 |
Relative Strength Index (RSI) | 59.41 |
Average Volume (20 Days) | 139,267 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, illimity Bank had revenue of EUR -957,000 and -179.14 million in losses. Loss per share was -2.16.
Revenue | -957,000 |
Gross Profit | -957,000 |
Operating Income | -190.04M |
Pretax Income | -240.69M |
Net Income | -179.14M |
EBITDA | n/a |
EBIT | n/a |
Loss Per Share | -2.16 |
Balance Sheet
The company has 424.23 million in cash and 1.64 billion in debt, giving a net cash position of -1.22 billion or -14.67 per share.
Cash & Cash Equivalents | 424.23M |
Total Debt | 1.64B |
Net Cash | -1.22B |
Net Cash Per Share | -14.67 |
Equity (Book Value) | 784.49M |
Book Value Per Share | 9.38 |
Working Capital | -4.81B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | 19,857.68% |
Pretax Margin | 25,150.05% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 6.13%.
Dividend Per Share | 0.25 |
Dividend Yield | 6.13% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | 2.49% |
Shareholder Yield | 8.61% |
Earnings Yield | -53.07% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |